Market Overview 2022-2027
The latest research study “Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global infertility drugs market reached a value of US$ 3.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.95 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download free sample brochure: https://www.imarcgroup.com/infertility-drugs-market/requestsample
Industry Definition and Application:
Infertility drugs consist of numerous medications that are used to treat infertility and improve the reproductive health of an individual. Some of the commonly used infertility drugs include aromatase inhibitors, gonadotrophins, biguanides, ovulatory stimulants, selective estrogen receptor modulators (SERMs), dopamine agonists, tricyclic antidepressants, etc. These drugs function by stimulating ovulation and follicle development of the ovary in women, as well as help to restore testosterone levels and improve the quality of sperm in men.
Global Infertility Drugs Market Trends and Drivers:
The growing incidences of infertility and miscarriages, particularly among the modern couples, are primarily driving the adoption of infertility drugs. In line with this, the rising consumer awareness towards several benefits of infertility drugs in enhancing the chances of pregnancy in couples is also augmenting the market growth on a global level. Furthermore, numerous initiatives are being undertaken by the NGOs and leading product manufacturers for improving the visibility of the available treatment options, thereby catalyzing the demand for infertility drugs. Additionally, various key players are investing in R&D activities to launch innovative infertility drugs with enhanced efficacy, fewer side effects, lower dosage requirements, etc. Several other factors, including the escalating demand for generic medicines, rising consumer expenditure capacities, improving healthcare infrastructure, etc., are expected to drive the global infertility drugs market in the coming years.
Click here to view detailed information with table of content: https://bit.ly/3NyUphc
|Infertility Drugs Market Report Scope|
|Market size value in 2021||US$ 3.47 Billion|
|Market forecast in 2027||US$ 4.95 Billion|
|Growth Rate||CAGR of 5.70% from 2022 to 2027|
|Base year for estimation||2021|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Segments covered||Drug Class, Route of Administration, Distribution Channel, End User and Region|
|Regional scope||North America, Europe, Asia-Pacific, Latin America, Middle East and Africa|
|Key companies profiled||Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,|
|Customization preview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
The report has been segmented the market into following categories:
Breakup by Drug Class:
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
Breakup by Route of Administration:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
Breakup by End User:
- North America
- United States
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
List of Major Key Players:
The major players in the market are Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Explore Latest Market Research Reports by IMARC Group:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800